rs199818971

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_001159702.3(FHL1):​c.797G>A​(p.Arg266Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000281 in 1,208,996 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R266W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 21)
Exomes 𝑓: 0.000030 ( 0 hom. 9 hem. )

Consequence

FHL1
NM_001159702.3 missense

Scores

2
2
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.55

Publications

1 publications found
Variant links:
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]
FHL1 Gene-Disease associations (from GenCC):
  • X-linked myopathy with postural muscle atrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • myopathy, reducing body, X-linked, early-onset, severe
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • reducing body myopathy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked Emery-Dreifuss muscular dystrophy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked scapuloperoneal muscular dystrophy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.26398277).
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.0000301 (33/1097998) while in subpopulation NFE AF = 0.0000344 (29/841984). AF 95% confidence interval is 0.0000242. There are 0 homozygotes in GnomAdExome4. There are 9 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAdExome4 at 9 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FHL1NM_001159702.3 linkc.797G>A p.Arg266Gln missense_variant Exon 7 of 8 ENST00000394155.8 NP_001153174.1
FHL1NM_001159699.2 linkc.737-520G>A intron_variant Intron 5 of 5 ENST00000370683.6 NP_001153171.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FHL1ENST00000394155.8 linkc.797G>A p.Arg266Gln missense_variant Exon 7 of 8 5 NM_001159702.3 ENSP00000377710.2
FHL1ENST00000370683.6 linkc.737-520G>A intron_variant Intron 5 of 5 1 NM_001159699.2 ENSP00000359717.1

Frequencies

GnomAD3 genomes
AF:
0.00000901
AC:
1
AN:
110998
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000189
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000110
AC:
2
AN:
181049
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000124
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000301
AC:
33
AN:
1097998
Hom.:
0
Cov.:
31
AF XY:
0.0000248
AC XY:
9
AN XY:
363432
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26397
American (AMR)
AF:
0.0000284
AC:
1
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.0000516
AC:
1
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54136
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40513
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4101
European-Non Finnish (NFE)
AF:
0.0000344
AC:
29
AN:
841984
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46069
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000901
AC:
1
AN:
110998
Hom.:
0
Cov.:
21
AF XY:
0.00
AC XY:
0
AN XY:
33192
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30420
American (AMR)
AF:
0.00
AC:
0
AN:
10501
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2641
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3529
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2559
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5957
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.0000189
AC:
1
AN:
52998
Other (OTH)
AF:
0.00
AC:
0
AN:
1477
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.00000831
AC:
1
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

X-linked myopathy with postural muscle atrophy Uncertain:1
Sep 02, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Jul 11, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis suggests that this missense variant does not alter protein structure/function; Reported using an alternate transcript of the gene; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.15
T;T
FATHMM_MKL
Benign
0.56
D
LIST_S2
Benign
0.84
T;.
M_CAP
Benign
0.056
D
MetaRNN
Benign
0.26
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;N
PhyloP100
2.5
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-0.57
N;N
REVEL
Benign
0.17
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.97
D;D
Vest4
0.21
MutPred
0.42
Loss of methylation at R266 (P = 0.0334);Loss of methylation at R266 (P = 0.0334);
MVP
0.87
MPC
1.5
ClinPred
0.52
D
GERP RS
3.5
Varity_R
0.46
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199818971; hg19: chrX-135291510; COSMIC: COSV61780957; COSMIC: COSV61780957; API